4.7 Article

Pathogenic Protein Seeding in Alzheimer Disease and Other Neurodegenerative Disorders

Journal

ANNALS OF NEUROLOGY
Volume 70, Issue 4, Pages 532-540

Publisher

WILEY
DOI: 10.1002/ana.22615

Keywords

-

Funding

  1. German Federal Ministry of Education and Research
  2. Competence Network on Degenerative Dementias [BMBF-01GI0705]
  3. NIH NCRR [RR-00165, PO1AG026423, P50AG025688]
  4. CART Foundation

Ask authors/readers for more resources

The misfolding and aggregation of specific proteins is a seminal occurrence in a remarkable variety of neurodegenerative disorders. In Alzheimer disease (the most prevalent cerebral proteopathy), the two principal aggregating proteins are beta-amyloid (A beta) and tau. The abnormal assemblies formed by conformational variants of these proteins range in size from small oligomers to the characteristic lesions that are visible by optical microscopy, such as senile plaques and neurofibrillary tangles. Pathologic similarities with prion disease suggest that the formation and spread of these proteinaceous lesions might involve a common molecular mechanism-corruptive protein templating. Experimentally, cerebral beta-amyloidosis can be exogenously induced by exposure to dilute brain extracts containing aggregated A beta seeds. The amyloid-inducing agent probably is A beta itself, in a conformation generated most effectively in the living brain. Once initiated, A beta lesions proliferate within and among brain regions. The induction process is governed by the structural and biochemical nature of the A beta seed, as well as the attributes of the host, reminiscent of pathogenically variant prion strains. The concept of prionlike induction and spreading of pathogenic proteins recently has been expanded to include aggregates of tau, alpha-synuclein, huntingtin, superoxide dismutase-1, and TDP-43, which characterize such human neurodegenerative disorders as frontotemporal lobar degeneration, Parkinson/Lewy body disease, Huntington disease, and amyotrophic lateral sclerosis. Our recent finding that the most effective A beta seeds are small and soluble intensifies the search in bodily fluids for misfolded protein seeds that are upstream in the proteopathic cascade, and thus could serve as predictive diagnostics and the targets of early, mechanism-based interventions. Establishing the clinical implications of corruptive protein templating will require further mechanistic and epidemiologic investigations. However, the theory that many chronic neurodegenerative diseases can originate and progress via the seeded corruption of misfolded proteins has the potential to unify experimental and translational approaches to these increasingly prevalent disorders. ANN NEUROL 2011;70:532-540

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available